NIH-funded research R01 grant

Investigating how certain cells in the lungs behave in pulmonary hypertension

Official title: Pulmonary Artery Endothelial Cell Endotypes and the Role of Anoikis Resistance in Pulmonary Hypertension

Funded at Rhode Island Hospital · NIH-11047124 · Data updated 2026-11-12

This study is looking at how certain cells in the lungs behave in people with pulmonary arterial hypertension (PAH) to find out why they don’t die off as expected, which could help us discover new ways to treat this condition.

More Hypertension research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRhode Island Hospital
NIH-funded
Lab location1 site (Providence, United States)
Project startMarch 1, 2025
Project endDecember 31, 2028
Funding year2025
Award (this year)$692,768
NIH project number1R01HL174007-01A1
Project IDNIH-11047124 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with pulmonary arterial hypertension, particularly those undergoing right heart catheterization.

Less likely to help

Patients with mild pulmonary hypertension or those without a confirmed diagnosis of pulmonary arterial hypertension may not benefit from this research.

What this research studies

This research focuses on pulmonary arterial hypertension (PAH), a serious condition characterized by dysfunction in the cells lining the blood vessels of the lungs. The team will collect endothelial cells from patients undergoing right heart catheterization, a common diagnostic procedure for PAH, and analyze these cells to understand their behavior and characteristics. By examining how these cells resist programmed cell death when detached from the vessel wall, the researchers aim to uncover new insights into the disease's progression and potential treatment targets.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that improve outcomes for patients with pulmonary hypertension.

How similar studies have gone: Previous research has shown promising results in understanding endothelial cell behavior in other vascular diseases, suggesting that this approach may yield valuable insights in PAH as well.

Where this research is happening

  • Rhode Island Hospital
    Providence, United States
    Active

Researchers

  • Principal investigator: Ventetuolo, Corey E — Rhode Island Hospital
  • Study coordinator: Ventetuolo, Corey E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.